Cytochrome P4501B1 mediates induction of bone marrow cytotoxicity and preleukemia cells in mice treated with 7,12-dimethylbenz[a]anthracene

Cancer Research

Volumn 60, Issue 13, 2000, Pages 3454-3460

  Heidel, Shawn M ^a   MacWilliams, Peter S ^a   Baird, William M ^b   Dashwood, W Mohaiza ^b   Buters, Jeroen T M ^c   Gonzalez, Frank J ^d   Larsen, Michele C ^a   Czuprynski, Charles J ^a   Jefcoate, Colin R ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CYTOCHROME P450 ISOENZYME; ETHOXYRESORUFIN DEETHYLASE; POLYCYCLIC AROMATIC HYDROCARBON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW TOXICITY; CANCER SUSCEPTIBILITY; CONGENITAL GLAUCOMA; CONTROLLED STUDY; DNA ADDUCT; ENZYME DEFICIENCY; IMMUNOTOXICITY; MOUSE; NONHUMAN; PRELEUKEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; APOPTOSIS; ARYL HYDROCARBON HYDROXYLASES; BONE MARROW CELLS; CARCINOGENS; CROSSES, GENETIC; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; HUMANS; LEUKEMIA, EXPERIMENTAL; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PRELEUKEMIA;

EID: 0034234231     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Mastrangelo, G., Fadda, E., and Marzia, V. Polycyclic aromatic hydrocarbons and cancer in man. Environ. Health Perspect., 104: 1166-1170, 1996.
2. Hernandez-Boussard, T. M., and Hainaut, P. A. A specific spectrum of p53 mutations in lung cancer from smokers: review of mutations compiled in the IARC p53 database. Environ. Health Perspect., 106: 385-391, 1998.
3. Klebanoff, M. A., Clemens, J. D., and Read, J. S. Maternal smoking during pregnancy and childhood cancer. Am. J. Epidemiol., 144: 1028-1033, 1996.
4. Ji, B. T., Shu, X. O., Linet, M. S., Zheng, W., Wacholder, S., Gao, Y. T., Ying, D. M., and Jin, F. Paternal cigarette smoking and the risk of childhood cancer among offspring of nonsmoking mothers. J. Natl. Cancer Inst., 89: 238-244, 1997.
5. Finette, B. A., O'Neill, J. P., Vacek, P. M., and Albertini, R. J. Gene mutations with characteristic deletions in cord blood T lymphocytes associated with passive maternal exposure to tobacco smoke. Nat. Med., 4: 1144-1151, 1998.
6. Denissenko, M. F., Pao, A., Tang, M., and Pfeifer, G. P. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science (Washington DC), 274: 430-432, 1996.
7. Thurmond, L. M., Lauer, L. D., House, R. V., Cook, J. C., and Dean, J. H. Immunosuppression following exposure to 7,12-dimethylbenz[a]anthracene (DMBA) in Ah-responsive and Ah-nonresponsive mice. Toxicol. Appl. Pharmacol., 91: 450-460, 1987.
8. Salas, V. M., and Burchiel, S. W. Apoptosis in Daudi human B cells in response to benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol. Toxicol. Appl. Pharmacol., 151: 367-376, 1998.
9. Yamaguchi, K., Near, R. I., Matulka, R. A., Schneider, A., Tosselli, P., Trombino, A. F., and Sherr, D. H. Activation of the aryl hydrocarbon receptor/transcription factor and bone marrow stromal cell-dependent preB cell apoptosis. J. Immunol., 158: 2165-2173, 1997.
10. Pelkonen, O., and Nebert, D. W. Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacol. Rev., 34: 189-222, 1982.
11. Balmain, A., and Pragnell, I. B. Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene. Nature (Lond.), 303: 72-74, 1983.
12. Savas, U., Carstens, C. P., and Jefcoate, C. R. Biological oxidations and P450 reactions: recombinant mouse CYPIB1 expressed in Escherichia coli exhibits selective binding by polycyclic hydrocarbons and metabolism which parallels C3H10T1/2 cell microsomes but differs from human recombinant CYPIB1. Arch. Biochem. Biophys., 347: 181-192, 1997.
13. Wilson, N. M., Christou, M., Turner, C. R., Wrighton, S. A., and Jefcoate, C. R. Binding and metabolism of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene by seven purified forms of cytochrome P-450. Carcinogenesis (Lond.), 5: 1475-1483, 1984.
14. Gonzalez, F. J., and Lee, Y. H. Constitutive expression of hepatic cytochrome P450 genes. FASEB J., 10: 1112-1117, 1996.
15. Savas, U., Bhattacharyya, K. K., Christou, M., Alexander, D. L., and Jefcoate, C. R. Mouse cytochrome P-450EF, representative of a new 1B subfamily of cytochrome P-450s: cloning, sequence determination, and tissue expression. J. Biol. Chem., 269: 14905-14911, 1994.
16. Sutter, T. R., Tang, Y. M., Hayes, C. L., Wo, Y. Y. P., Jabs, E. W., Li, X., Yink, H., Cody, C. W., and Greenlee, W. F. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome p450 that maps to chromosome 2. J. Biol. Chem., 269: 13092-13099, 1994.
17. Heidel, S. M., Czuprynski, C. J., and Jefcoate, C. R. Bone marrow stromal cells constitutively express high levels of cytochrome P4501B1 that metabolize 7,12-dimethylbenz[a]anthracene. Mol. Pharmacol., 54: 1000-1006, 1998.
18. Stoilov, I., Akarsu, A. N., and Sarfarazi, M. Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21. Hum. Mol. Genet., 6: 641-647, 1997.
19. Buters, J. T., Sakai, S., Richter, T., Pineau, T., Alexander, D. L., Savas, U., Doehmer, J., Ward, J. M., Jefcoate, C. R., and Gonzalez, F. J. Cytochrome P4501B1 determines susceptibility to 7,12-dimethylbenz[a]anthracene-induced lymphomas. Proc. Natl. Acad. Sci. USA, 96: 1977-1982, 1999.
20. Pietrangeli, C. E., Hayashi, S., and Kincade, P. W. Stromal cell lines which support lymphocyte growth: characterization, sensitivity to radiation and responsiveness to growth factors. Eur. J. Immunol., 18: 863-872, 1988.
21. Whitlock, C. A., and Witte, O. N. Long-term culture of B lymphocytes and their precursors from murine bone marrow. Proc. Natl. Acad. Sci. USA, 79: 3608-3612, 1982.
22. Pottenger, L. H., and Jefcoate, C. R. Characterization of a novel cytochrome p450 from the transformable cell line. C3H/10T1/2. Carcinogenesis (Lond.), 11: 321-327, 1990.
23. Melendez-Colon, V. J., Smith, C. A., Seidel, A., Luch, A., Platt, K. L., and Baird, W. M. Formation of stable adducts and absence of depurinating DNA adducts in cells and DNA treated with the potent carcinogen dibenzo[a,l]pyrene or its diol epoxides. Proc. Natl. Acad. Sci. USA, 94: 13542-13547, 1997.
24. Medina, D., Stockman, G., and Griswold, D. Significance of chemical carcinogen-induced immunosuppression in mammary tumorigenesis in BALB-c mice. Cancer Res., 34: 2663-2668, 1974.
25. Fohlmeister, I., Schaefer, H. E., and Fischer, R. J. On the pathogenesis of preleukemic myelodysplastic syndromes: development of a dysplastic hemopoietic proliferation in the rat after a single pulse dose of dimethylbenz(a)anthracene (DMBA). Cancer Res. Clin. Oncol., 104: 249-261, 1982.
26. Ginsberg, G. L., and Atherholt, T. B. Transport of DNA-adducting metabolites in mouse serum following benzo[a]pyrene administration. Carcinogenesis (Lond.), 10: 673-679, 1989.
27. Luch, A., Coffing, S. L., Tang, Y. M., Schneider, A., Soballa, V., Greim, H., Jefcoate, C. R., Seidel, A., Greenlee, W. F., Baird, W. M., and Doehmer, J. Stable expression of human cytochrome P450 1B1 in V79 Chinese hamster cells and metabolically catalyzed DNA adduct formation of dibenzo[a,l]pyrene. Chem. Res. Toxicol., 11: 686-695, 1998.
28. Kincade, P. W. Experimental models for understanding B lymphocyte formation. Adv. Immunol., 41: 181-267, 1987.
29. Legraverend, C., Harrison, D. E., Ruscelti, F. W., and Nebert, D. W. Bone marrow toxicity induced by oral benzo[a]pyrene: protection resides at the level of the intestine and liver. Toxicol. Appl. Pharmacol., 70: 390-401, 1983.
30. Koeffler, H. P. Myelodysplastic syndromes (preleukemia). Semin. Hematol., 23: 284-299, 1986.
31. Osaka, M., Matsuo, S., Koh, T., and Sugiyama, T. Loss of heterozygosity at the N-ras locus in 7,12-dimethylbenz[a] anthracene-induced rat leukemia. Mol. Carcinog., 18: 206-212, 1997.
32. Qing, W. G., Conti, C. J., Labate, M., Johnston D., Slaga, T. J., and MacLeod, M. C. Induction of mammary cancer and lymphoma by multiple, low oral doses of 7,12-dimethylbenz[a]anthracene in SENCAR mice. Carcinogenesis (Lond.), 18: 553-559, 1997.
33. Vericat, J. A., Cheng, S. C., and Dipple, A. Absolute stereochemistry of the major 7,12-dimethylbenz[a]anthracene-DNA adducts formed in mouse cells. Carcinogenesis (Lond.), 10: 567-570, 1989.
34. Miyata, M., Kudo, G., Lee, Y. H., Yang, T. J., Gelboin, H. V., Fernandez-Salguero, P., Kimura, S., and Gonzalez, F. J. Targeted disruption of the microsomal epoxide hydrolase gene: microsomal epoxide hydrolase is required for the carcinogenic activity of 7,12-dimethylbenz[a]anthracene. J. Biol. Chem., 274: 23963-23968, 1999.
35. Todorovic, R., Ariese, F., Devanesan, P., Jankowiak, R., Small, G. J., Rogan, E., and Cavalieri, E. Determination of benzo[a]pyrene-and 7,12-dimethylbenz[a]anthracene-DNA adducts formed in rat mammary glands. Chem. Res. Toxicol., 10: 941-947, 1997.
36. Heidel, S. M., Holston, K., Buters, T. M., Gonzalez, F. J., Jefcoate, C. R., and Czuprynski, C. J. Bone marrow stromal cell cytochrome P4501B1 is required for preB cell apoptosis induced by 7,12-dimethylbenz[a]anthracene. Mol. Pharmacol., 56: 1317-1323, 1999.
37. Dean, J. H., Ward, E. C., Murray, M. J., Lauer, L. D., House, R. V., Stillman, W., Hamilton, T. A., and Adams, D. O. Immunosuppression following 7,12-dimelhylbenz[a]anthracene exposure in B6C3F1 mice: altered cell-mediated immunity and tumor resistance. Int. J. Immunopharmacol., 8: 189-198, 1986.
38. Davila, D. R., Romero, D. L., and Burchiel, S. W. Human T cells are highly sensitive to suppression of mitogenesis by polycyclic aromatic hydrocarbons and this effect is differentially reversed by α-naphthoflavone. Toxicol. Appl. Pharmacol., 139: 333-341, 1996.
39. Black, K. A., McFarland, R. D., Grisham, J. W., and Smith, G. J. S-phase block and cell death in human lymphoblasts exposed to benzo[a]pyrene diol epoxide or N-acetoxy-2-acetylaminofluorene. Toxicol. Appl. Pharmacol., 97: 463-472, 1989.
40. Lotem, J., and Sachs, L. Control of apoptosis in hematopoiesis and leukemia by cytokines, tumor suppressor and oncogenes. Leukemia (Baltimore), 10: 925-931, 1996.
41. Lotem, J., and Sachs, L. Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor β1 and cancer chemotherapy compounds in myeloid leukemic cells. Blood, 80: 1750-1757, 1992.
42. Shimada, T., Hayes, C. L., Yamazaki, H., Amin, S., Hecht, S. S., Guengerich, F. P., and Sutter, T. R. Activation of chemically diverse procarcinogens by human cytochrome P4501B1. Cancer Res., 56: 2979-2984, 1996.